---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-066482"
form_type: "8-K"
ticker: "IRIX"
cik: "0001006045"
company_name: "IRIDEX CORP"
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T20:44:16.525816+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Iridex wins broader Medicare coverage for cyclophotocoagulation after LCD appeal

## Summary
- Five Medicare Administrative Contractors corrected CPC coverage criteria; 'AND' changed to 'OR', broadening patient access.
- Patient criteria now: failed trabeculectomy/tube shunt, minimal useful vision with elevated IOP, or need pain relief.
- CEO David Bruce thanked MACs for quick action; appeal supported by Dr. Shan Lin, co-author of the 2001 AAO paper.
- Iridex preparing subsequent appeal to further cover poor surgical candidates and emergency situations.
- Change aligns LCDs with 2001 AAO paper; Iridex cites 22 years of technological advances and clinical studies.

## SEC filing metadata
- accession: 0000950170-23-066482
- form_type: 8-K
- ticker: IRIX
- cik: 0001006045
- company_name: IRIDEX CORP
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006045/000095017023066482/0000950170-23-066482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006045/000095017023066482/irix-20231127.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-066482
- JSON: https://secwatch.observer/filing/0000950170-23-066482.json
- Plain text: https://secwatch.observer/filing/0000950170-23-066482.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.